Clinical trial
Erectile Dysfunction/Prostate/RT/Androgen
NCT00242138 · University Health Network, Toronto, Other · Completed
Key facts
| NCT number | NCT00242138 |
|---|---|
| Title | Erectile Dysfunction/Prostate/RT/Androgen |
| Official title | A Cross-Sectional Study of Erectile Dysfunction in Patients With Locally Advanced Prostate Cancer Who Have Undergone Radiotherapy and Prolonged Pharmacological Androgen Ablation |
| Lead sponsor | University Health Network, Toronto, Other |
| Collaborators | Princess Margaret Hospital, Canada |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostatic Neoplasms |
| Intervention type | Behavioral |
| Interventions | Erectile Dysfunction |
| Enrollment | 50 |
| Start date | Mar 1, 2000 |
| Completion | Apr 1, 2004 |
| First posted | Oct 19, 2005 |
| Last update posted | Feb 9, 2016 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: